More life added in this Week’s Analysis!
Aksjeanalyser.com takes a closer look at a Life Science company:
AddLife B
The stock is listed on Nasdaq Stockholm, Nordic Large Cap. AddLife.
(ticker ALIFB )
The company has presented its Q3-2025 results and is rising strongly this morning, Thursday October 23rd-2025. Read more below, by the technical analysis of AddLife.
About the company AddLife B
(ticker on Nasdaq Stockholm: ALIF B)
AddLife is a Life Science company that focuses on the development, manufacturing and distribution of medical equipment and laboratory products. The company’s products are aimed at healthcare institutions and research laboratories. The business is global with a primary presence in Europe, North America and Asia. AddLife was founded in 2015 and is headquartered in Stockholm, Sweden.
For more information about the company, visit their website here.
AddLife B is one of the major companies listed on Nasdaq Stockholm and has a market capitalization of around SEK 22.8 billion at the current share price.
Technical Analysis of AddLife B
(ticker on Nasdaq Stockholm: ALIF B)
AddLife B (ALIF B) is rising this morning after delivering a strong Q3-2025 report.
The stock is now in the process of triggering a very strong technical buy signal when breaking above the SEK 195.00 – 200.00 level.
An established break above the SEK 200.00 level will trigger a strong technical buy signal for the AddLife share, and the potential for the share will then be around SEK 300.00 – 400.00 in the 6-12 month term.
The stock is above both 50-day and 200-day moving averages and the 50-day moving average is above the 200-day moving average. This confirms that the stock is in a positive trend both in the short and long term.
The BEST Model in Vikingen is also in a buy signal for the AddLife share. This popular and effective technical analysis model was developed by Peter Östevik. He finalized the the BEST Model around 2019, and after 30 years of experience in technical analysis and Vikingen Financial Software.
Based on this overall positive technical picture for AddLife, Aksjeanalyser.com considers the share to be a very interesting buy candidate around the current price level.
The potential for the share is therefore estimated to be up to SEK 300.00 – 400.00 in 6-12 months’ time.
What could possibly change the current positive technical picture, would be if the share were to fall below the 50-day moving average and below the important technical support level around SEK 180.00.
Media news about AddLife
AddLife B (ALIF B) released its Q3-2025 earnings report this morning, Thursday October 23rd-2025.
Below is some related information to the report:
Interim report January 1 – September 30, 2025
“Good organic growth and strong earnings trend “AddLife’s companies performed strongly during the quarter. Organic growth was good, margins continued to improve, earnings strengthened significantly and the debt/equity ratio was reduced, in line with our priorities and ambitions.” says Fredrik Dalborg, President and CEO
AddLife’s interim report for Q3 2025 has today been published online in Swedish and English on the company’s website. The interim report can be downloaded as a pdf-version.
THIRD QUARTER
Net sales increased by 4 percent to SEK 2,429 million (2,344). Organic growth excluding exchange rate fluctuations was 6 percent and acquired growth amounted to 1 percent.
EBITA excluding items affecting comparability increased by 17 percent to SEK 270 million (230), corresponding to an EBITA margin of 11.1 percent (9.8).
Profit after tax increased by 228 percent to SEK 82 million (25).
Earnings per share amounted to SEK 0.66 (0.19).
Cash flow from operating activities amounted to SEK 145 million (137).
JANUARY — SEPTEMBER 2025
Net sales increased by 3 percent to SEK 7,709 million (7,468). Organic growth excluding exchange rate fluctuations was 4 percent and acquired growth amounted to 1 percent.
EBITA excluding items affecting comparability increased by 12 percent to SEK 920 million (819), corresponding to an EBITA margin of 11.9 percent (11.0).
Profit after tax increased by 89 percent to SEK 302 million (160).
Earnings per share amounted to SEK 2.47 (1.30). For the last 12-month period, earnings per share amounted to SEK 3.23 (0.98).
Cash flow from operating activities amounted to SEK 504 million (429).
The equity/assets ratio amounted to 42 percent (41).
Return on working capital (R/WC) amounted to 55 percent (51).
In April, the acquisition of Edge Medical Ltd. in the UK was completed. The acquisition is expected to add annual net sales of approximately SEK 90 million. Stockholm, October 23, 2025.
Don’t miss out on Vikingen’s new offer!
Until October 31st, you get a 30% discount on Nordic Complete, annual subscription! Use the code 2OCT30
Here is a link to Vikingen’s online store where you can choose other Vikingen programs and add-ons that suit you best.
Vikingen Financial Software reminds you that past positive results do not always indicate future profits and that all trading is at your own risk.
Sincerely yours
